| Literature DB >> 35924057 |
Olga Bukhtiyarova1, Amna Abderrazak1, Yohann Chiu1,2, Stephanie Sparano1, Marc Simard2,3, Caroline Sirois1,2.
Abstract
Introduction: The ongoing collection of large medical data has created conditions for application of artificial intelligence (AI) in research. This scoping review aimed to identify major areas of interest of AI applied to health care administrative data.Entities:
Keywords: artificial intelligence; health care administrative database; natural language processing; pharmacotherapy; scoping review
Year: 2022 PMID: 35924057 PMCID: PMC9340156 DOI: 10.3389/fphar.2022.944516
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Venn diagram of the initial database search results. Legend: Each circle represents the number of articles related to each topic. There were 14,864 articles that overlapped the three topics. AI, artificial intelligence.
FIGURE 2Article selection and data extraction strategy. Legend: The three main steps for article selection included titles and abstract screening, full test reviews, and data extraction. Classic (manual) approach allowed categorizing publications according to the principal areas of applied AI research. Automated method with the use of NLP allowed extraction of terms from three different groups, and their quantification.
FIGURE 3Number of published original articles on AI research applied to health care administrative database per year. Legend: The period 2003–2012 was characterized by a few publications per year and points to an emerging interest in the field. These research topics were rapidly growing in popularity in the following years, most significantly since 2018.
Principal areas of AI application for health care administrative database.
| Area of interest | Number of articles | % from total |
|---|---|---|
| Health diagnostics or health outcome prediction | 110 | 32.0 |
| Medical data representation, clinical pathways, and temporality | 74 | 21.5 |
| Medication patterns, ADE, DDI | 52 | 15.1 |
| Medical data clustering | 47 | 13.7 |
| Multimorbidity | 45 | 13.1 |
| Combination of medications and treatment patterns | 23 | 6.7 |
| Subpopulations | 9 | 2.6 |
| Polypharmacy | 6 | 1.7 |
| Missing or biased medical data | 3 | 0.9 |
| Reinforcement learning | 3 | 0.9 |
ADE, adverse drug events; DDI, drug-drug interaction.
Principal AI methods applied to health care administrative database.
| Methods | Years | Total (%) | |||||
| 2003–2005 | 2006–2008 | 2009–2011 | 2012–2014 | 2015–2017 | 2018–2020 | ||
| Regression | 1 | 2 | 4 | 9 | 35 | 88 | 150 (44.6) |
| Correlation | 1 | 1 | 5 | 4 | 26 | 52 | 105 (31.3) |
| Decision tree | 4 | 0 | 3 | 10 | 28 | 48 | 102 (30.4) |
| Cluster analysis | 0 | 1 | 3 | 10 | 22 | 58 | 101 (30.1) |
| Random forest | 0 | 1 | 0 | 3 | 16 | 33 | 59 (17.6) |
| Support vector machine | 0 | 0 | 0 | 4 | 9 | 24 | 41 (12.2) |
| Recurrent neural network | 0 | 0 | 0 | 0 | 6 | 32 | 39 (11.6) |
| Bootstrap | 0 | 0 | 1 | 5 | 9 | 18 | 36 (10.7) |
| Naïve Bayes | 0 | 0 | 1 | 4 | 6 | 21 | 31 (9.2) |
| Long short-term memory | 0 | 0 | 0 | 0 | 4 | 24 | 29 (8.6) |
| Apriori | 3 | 3 | 4 | 5 | 6 | 8 | 28 (8.3) |
| Boosting | 0 | 0 | 0 | 1 | 2 | 20 | 26 (7.7) |
| k-Nearest neighbors | 0 | 0 | 1 | 1 | 5 | 15 | 24 (7.1) |
| Multi-layer perceptron | 0 | 0 | 1 | 0 | 4 | 14 | 21 (6.3) |
| Principal component analysis | 0 | 0 | 2 | 3 | 3 | 10 | 18 (5.4) |
Note: Linear discriminant analysis, cox models, hierarchical clustering, autoencoders, hidden Markov models, adaboost, reinforcement learning, generative adversarial networks, and self-organizing maps were mentioned in less than 5% of the articles and thus not included in Table 2.
FIGURE 4Principal health-related terms mentioned in AI applied studies. Legend: The larger font corresponds to the higher number of research articles where the terms were found.
FIGURE 5Frequently used pharmacotherapy-related terms. Legend: (A) The larger font of the word cloud corresponds to a larger number of articles where the terms were found. (B) The table presents information about the number of mentions belonging to ATC level 1 classes, the number of ATC level 5 medications found in the articles, and examples of the most frequently mentioned medications. Some medications may be included in more than one ATC class (for example, dexamethasone appears in classes D, H and R), since the medication indications were not extracted. Some level 1 ATC classes are thus overrepresented (for example, the circumstances in which ibuprofen was studied may not belong to class G (intravaginal use), but rather to class M (anti-inflammatory agent), but ibuprofen has been listed in every ATC class to which it may belong).